John keller m.d. to join aclarion as a key opinion leader surgeon advisor

Aclarion key opinion leader program supports focused strategy of building strong clinical evidence and payer community advocacy to drive adoption of nociscantm solution broomfield, co / accesswire / october 3, 2022 / aclarion, inc., ("aclarion" or the "company") (nasdaq:acon)(nasdaq:aconw), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, announced today that john keller m.d., chief of neurosurgery at university of michigan health-west and neurosurgeon at great lakes neurosurgical associates in grand rapids, mi, will advise the company as a key opinion leader (kol) in the greater michigan market.
ACON Ratings Summary
ACON Quant Ranking